Tranexamic Acid
- Product NDC
- 70771-1989
- Requested package NDC
- 70771-1989-3
- 11-digit product format
- 707711989
- Labeler code
- 70771
- Product ID
- 70771-1989_51633175-a071-4fe7-bb98-e4743cf19d10
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tranexamic Acid
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA221213
- Marketing category
- ANDA
- Marketing start
- 2026-11-01
- Substance
- TRANEXAMIC ACID
- Active strength
- 650 mg/1
- Pharmacologic classes
- Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A221213-001 | TRANEXAMIC ACID | TRANEXAMIC ACID | 650MG | TABLET / ORAL | AB | 2026-10-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A221213-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A221213-001 | TRANEXAMIC ACID | 650MG | TABLET / ORAL | AB | 2026-10-27 | d4dbc9d85df4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A221213-001 | AB | 1 | d4dbc9d85df4… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tranexamic Acid
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TRANEXAMIC ACID | 650 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6T84R30KC1 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 883826 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| ed552a1b-07c0-4379-92f6-fc99cca5bec9 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tranexamic Acid | TRANEXAMIC ACID | Zydus Lifesciences Limited | ed552a1b-07c0-4379-92f6-fc99cca5bec9 | 2026-10-31 | 221213 ANDA221213 70771-1989-3 70771-1989 70771198903 | |
| Tranexamic Acid | TRANEXAMIC ACID | Viona Pharmaceuticals Inc | 40e3e10f-a787-42f2-a2c0-0ce2cb1ab916 | 2026-10-31 | Warnings, Adverse reactions | 221213 ANDA221213 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 70771-1989-3 | 70771198903 | 30 TABLET in 1 BOTTLE (70771-1989-3) | 30 tablet | 2026-11-01 | No | No | Current |